NODELMAN OLEG — SEC Form 4 filings
SEC reporting owner CIK 1454385. 11 Form 4 filings on record with FilingPulse; latest filed 2026-01-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2025-01-02 to 2026-01-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 25 legs across 10 filings — 4,471,067 shares, $67,170,949 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 2,077,779 shares @ $18.00 ($37,400,022) in Aktis Oncology, Inc., filed 2026-01-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | Director | 1 | 2 legs · 2,222,222 sh · $39,999,996 | — | 10 |
| Zymeworks Inc. (ZYME) | Director, 10% owner | 9 | 20 legs · 2,163,747 sh · $26,071,310 | — | 3 |
| ANAPTYSBIO, INC (ANAB) | Director, 10% owner | 1 | 3 legs · 85,098 sh · $1,099,642 | — | — |
Form 4 filings — NODELMAN OLEG
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-12 | 4 | Aktis Oncology, Inc. (AKTS) jointly with EcoR1 Capital, LLC | Conversion (C): 2,270,879 · Conversion (C): 202,862 · Conversion (C): 128,506 · Purchase (P): 2,077,779 @ $18 · Purchase (P): 144,443 @ $18 · Conversion (C): 9,913,810 (derivative) · +6 more | EDGAR |
| 2025-06-27 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Option exercise/expiry (X): 5,086,480 @ $0.00 · Tax withholding (F): 41 @ $12.71 · Option exercise/expiry (X): 5,086,521 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 49,502 @ $11.43 · Purchase (P): 5,919 @ $11.78 | EDGAR |
| 2025-04-18 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 73,953 @ $11.16 · Purchase (P): 54,760 @ $11.52 | EDGAR |
| 2025-04-07 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 120,770 @ $11.84 · Purchase (P): 196,438 @ $11.17 | EDGAR |
| 2025-04-02 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 4,397 @ $11.75 · Purchase (P): 48,658 @ $11.60 · Purchase (P): 74,360 @ $11.85 | EDGAR |
| 2025-03-27 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 53,501 @ $12.91 · Purchase (P): 43,848 @ $12.24 | EDGAR |
| 2025-03-24 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 73,476 @ $12.93 · Purchase (P): 31,033 @ $12.78 · Purchase (P): 22,689 @ $13.08 | EDGAR |
| 2025-03-19 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 56,277 @ $12.23 · Purchase (P): 113,880 @ $12.65 · Purchase (P): 58,306 @ $12.64 | EDGAR |
| 2025-03-13 | 4 | Zymeworks Inc. (ZYME) jointly with EcoR1 Capital, LLC | Purchase (P): 320,690 @ $11.49 · Purchase (P): 292,934 @ $12.25 · Purchase (P): 468,356 @ $12.48 | EDGAR |
| 2025-01-02 | 4 | ANAPTYSBIO, INC (ANAB) jointly with EcoR1 Capital, LLC | Purchase (P): 65,184 @ $12.92 · Purchase (P): 13,268 @ $12.93 · Purchase (P): 6,646 @ $12.95 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1454385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →